Members Login
Username 
 
Password 
    Remember Me  
Post Info TOPIC: Mastitis Market Growth, Trends, Analysis, & Growth [2027]


Senior Member

Status: Offline
Posts: 167
Date:
Mastitis Market Growth, Trends, Analysis, & Growth [2027]
Permalink   


Mastitis Market Overview

The Global Mastitis Market is expected to reach over 18,338 Million USD by 2023, growing at approximately 15.07% CAGR during the forecast period (2017-2023). In the year 2017, the market had valued at USD 7,898.05 Million.

Mastitis refers to a kind of infection occurring in the tissues of mammary glands in the breast. The mastitis usually affects women who are breastfeeding as a result of a blocked duct. In cows, mastitis occurs as a result of chemical, mechanical, or thermal injury to the cow's udder.

Affected bovine and human population are driving the growth of the global mastitis market. With the various technological advancements in recent years, the global mastitis market has been witnessing many innovations in treatment methods and drugs to treat the infection.

Request Free Sample Copy at:

https://www.marketresearchfuture.com/sample_request/5379

Mastitis Market Segmentation

The global mastitis market can be segmented by type, treatment, end-user, and region.

On the basis of type, the global mastitis market is segmented into human mastitis and bovine mastitis. The segment bovine mastitis accounted for the major share in the global mastitis market in 2017. Whereas the subsegment contagious mastitis had valued at USD 3,843.23 MN in 2017 and is expected to exhibit a CAGR of 16.91 % during the forecast period (2017-2023). Environmental mastitis accounted for a 38 % of the share of bovine mastitis, in 2017.

On the basis of treatment, the mastitis market is segmented into antibiotics, pain relievers, surgery, vaccines, and others. Antibiotics by bovine treatment accounted for the valuation of USD 6,448.56 million in 2017. The antibiotics subsegment is further expected to register a CAGR of 16.56% throughout the forecast period.

On the basis of end-user, the mastitis market is segmented into hospitals, clinics, veterinary centers, and others. In 2018, the hospitals and clinics segment is expected to account for the largest share of the global mastitis market. Veterinary centers accounted for the largest share of the market in 2017.

The subsegment Veterinary centers by the end-user accounted for the valuation of approximately USD 6,326.34 million in 2017 and is projected to register a CAGR of 16.87% over the forecast period.

Mastitis Market Regional Analysis

The Americas region dominates the global mastitis market mainly due to the higher health care expenditures and the increasing prevalence of mastitis among the bovine population. The US backed by the growing prevalence of human mastitis, and bovines mastitis accounts for the major growth supporter to the regional market. The mastitis market in North America is expected to reach USD 7,054.58 Mn by 2023.

Europe mastitis market stands the second position, globally mainly due to the high prevalence of breast cancer. Moreover, factors such as the accessibility to advanced treatment facilities, rising government initiatives to promote healthy breastfeeding, and growing healthcare expenditures are fostering the growth of the regional market. The European mastitis market is expected to worth USD 5,275.18 Mn by 2023.

The mastitis market in the Asia Pacific region is expected to emerge as a promising market, growing rapidly due to the government initiatives of healthcare reforms. Increasing demand for advanced treatment therapies mainly in emerging economies such as China and India are leading the growth in the mastitis market in the region. The mastitis market in the APAC will reach the valuation of USD 5,000.41 Mn by 2023.

Mastitis Market Players

Globus Medical, Inc. (U.S.)

Depuy Synthes Inc. (Johnson & Johnson) (U.S.)

Smith & Nephew plc. (UK)

NuVasive, Inc. (U.S.)

Stryker Corporation (U.S.)

Integra LifeSciences Holdings Corporation (U.S.)

Zimmer Biomet Holdings, Inc. (U.S.)

Medtronic, plc (Ireland)

Wright Medical Group N.V. (Netherlands)

The Orthopedic Implant Company (U.S.)

Aesculap Implant Systems (U.S.)

Conmed Corporation (U.S.)

BioTek Instruments, Inc. (U.S.)

Arthrocare Corporation (U.S.)

among others are some key companies in the global Mastitis that are listed by MRFR for market research.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/mastitis-market-5379

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com



__________________
Page 1 of 1  sorted by
Quick Reply

Please log in to post quick replies.

Tweet this page Post to Digg Post to Del.icio.us


Create your own FREE Forum
Report Abuse
Powered by ActiveBoard